×
Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Japan Biopsy Devices Market

ID: MRFR/HC/54674-HCR
200 Pages
MRFR Team
June 2025

Japan Biopsy Devices Market Research Report: By Product Type (Biopsy Guns, Biopsy Guidance System, Biopsy Needles, Biopsy Forceps, Localization Wires, Others), By Application (Breast Biopsy, Prostate Biopsy, Liver Biopsy, Lung Biopsy, Gynecological Biopsy, Others), By Guidance (Ultrasound-Guided Biopsy, Stereotactic Guided Biopsy, MRI-Guided Biopsy, CT Guided Biopsy, Others) andBy End User (Hospitals & Clinics, Diagnostic & Imaging Centers, Academic & Research Institutes, Others)- Forecast to 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Options

Japan Biopsy Devices Market Summary

Industry Developments

The Japan Biopsy Devices Market has witnessed significant developments recently, particularly with an increasing focus on technological advancements and product innovation. In September 2023, Medtronic announced the launch of a new ultrasound-guided biopsy device, aiming to improve accuracy and patient outcomes in tissue sampling. Meanwhile, Hologic received approval for its latest imaging technology that enhances guidance for biopsy procedures. Also, Terumo has been expanding its product portfolio by introducing minimally invasive biopsy tools designed for increased patient comfort and improved efficacy in various clinical settings. In the realm of mergers and acquisitions, in June 2023, Boston Scientific completed its acquisition of a Japanese company specializing in biopsy technologies, strengthening its market position in the region. Moreover, the biopsy devices sector is expected to see continued growth, driven by rising cancer incidence and increasing healthcare expenditure in Japan. Several leading players like Olympus, Johnson and Johnson, and Smith and Nephew are also enhancing their R&D initiatives to align with the high demand for advanced biopsy solutions, reflecting a healthy competition in the evolving market landscape.

Report Scope

Report Scope:
Report Attribute/Metric Source:Details
MARKET SIZE 2018132.0(USD Million)
MARKET SIZE 2024140.5(USD Million)
MARKET SIZE 2035258.78(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR) 5.71% (2025 - 2035)
REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR2024
MARKET FORECAST PERIOD2025 - 2035
HISTORICAL DATA2019 - 2024
MARKET FORECAST UNITSUSD Million
KEY COMPANIES PROFILEDMedtronic, Karl Storz, Angiotech, Hologic, Terumo, Johnson & Johnson, C.R. Bard, Mediwin, Smith & Nephew, Biopsys, Baxter International, Boston Scientific, Olympus, Cook Medical
SEGMENTS COVEREDProduct Type, Application, Guidance, End User
KEY MARKET OPPORTUNITIESAging population driving demand, Advanced imaging technologies integration, Growth in cancer diagnosis, Increasing adoption of minimally invasive procedures, Rising healthcare expenditure and innovations
KEY MARKET DYNAMICStechnological advancements, increasing cancer prevalence, growing elderly population, rising demand for minimally invasive procedures, favorable reimbursement policies
COUNTRIES COVEREDJapan

Leave a Comment

FAQs

What is the estimated market value of the Japan Biopsy Devices market in 2024?

The Japan Biopsy Devices market is expected to be valued at 140.5 million USD in 2024.

What will be the projected market value of the Japan Biopsy Devices market in 2035?

The projected market value of the Japan Biopsy Devices market is expected to reach 258.78 million USD by 2035.

What is the expected CAGR for the Japan Biopsy Devices market from 2025 to 2035?

The expected CAGR for the Japan Biopsy Devices market is 5.71% from 2025 to 2035.

Which product type will dominate the Japan Biopsy Devices market by 2035?

By 2035, Biopsy Guns are expected to dominate the Japan Biopsy Devices market, valued at 57.0 million USD.

Who are the key players in the Japan Biopsy Devices market?

Major players in the Japan Biopsy Devices market include Medtronic, Karl Storz, Angiotech, and Hologic among others.

What will the market size for Biopsy Needles be in 2024?

The market size for Biopsy Needles is anticipated to be 40.0 million USD in 2024.

What are the growth opportunities in the Japan Biopsy Devices market?

Growth opportunities in the Japan Biopsy Devices market are driven by technological advancements and increasing health awareness in the population.

What is the market size for Biopsy Forceps in 2035?

The market size for Biopsy Forceps is projected to be 42.5 million USD in 2035.

How is the Japan Biopsy Devices market expected to grow by product types from 2025 to 2035?

The Japan Biopsy Devices market is expected to experience growth across all product types, particularly Biopsy Needles and Biopsy Guns during 2025 to 2035.

What impact does the competitive landscape have on the Japan Biopsy Devices market?

The competitive landscape is intensifying due to the presence of key players, driving innovation and strategies that influence market growth.

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions